Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 38)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
22-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: MEDIVATION INC5$25  View Abstract
21-Nov-09Standard & Poor's Quantitative ReportN/AMedivation Inc5$25  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: MEDIVATION -- MDVN1$4  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: CADX , MNKD , MDVN , NVD -- DRUGS3$4  View Abstract
17-Nov-09EconomicInvestorN/A"The Economy Matters" Report for MDVN: the economy's impact on MDVN's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
15-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for Medivation, Inc.40$65  View Abstract
15-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: MEDIVATION INC5$25  View Abstract
11-Nov-09Roth Capital Partners, Inc.Scott R. Henry CFA, Andrew VainoTransition Q1 (FY2010) In-Line, First Half Of 2010 Will Be Transitional5$10 4 Stars View Abstract
10-Nov-09Emerging Growth Equities , Ltd.Raymond A. Myers CFAMDVN: On track for pivotal AD data in 4-5 months.10$25  View Abstract
8-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: MEDIVATION INC5$25  View Abstract
Next 20
Brokerage Reports (Showing 1 to 10 of 17)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
11-Nov-09Roth Capital Partners, Inc.Scott R. Henry CFA, Andrew VainoTransition Q1 (FY2010) In-Line, First Half Of 2010 Will Be Transitional5$10 4 Stars View Abstract
10-Nov-09Emerging Growth Equities , Ltd.Raymond A. Myers CFAMDVN: On track for pivotal AD data in 4-5 months.10$25  View Abstract
5-Nov-09Roth Capital Partners, Inc.Research DepartmentMorning Call Summary25$75  View Abstract
5-Nov-09Brean Murray & Co., Inc.Jonathan M. Aschoff PhDMDVN: Reports 3Q09 Results – Expecting Connection Trial to Fail In 1H104$104 Stars  View Abstract
5-Nov-09Brean Murray & Co., Inc.Eric M. Beder, Jonathan M. Aschoff PhD, Andrey Glukhov CFA, Michael Gaugler, Daniel Fidell, Jose Haresco, Bret JonesMorning Insight (AWR, WRC, AMMD, PFWD, NKTR, CNSO, MDVN, SGMO, ELON, CHG, CNP, NST, NU, UIL, UTL, VVC, THQI)16$504 Stars 4 Stars View Abstract
5-Nov-09Roth Capital Partners, Inc.Scott R. Henry CFA, Andrew VainoBUY Now In Advance Of Phase 3 Dimebon Data in H1 20108$25 4 Stars View Abstract
4-Nov-09Roth Capital Partners, Inc.Research DepartmentMorning Call Summary27$75  View Abstract
4-Nov-09Thomson StreetEventsN/AMDVN - Event Transcript of Medivation, Inc. conference call, Nov. 04, 2009 / 4:30pm ET15$75  View Abstract
3-Nov-09Roth Capital Partners, Inc.Scott R. Henry CFA, Andrew Vaino2 More Phase 3 Studies of Dimebon Underway3$10 4 Stars View Abstract
29-Oct-09Emerging Growth Equities , Ltd.Raymond A. Myers CFAMDVN: Astellas is a gateway to the large urology market10$25  View Abstract
Next 7
Independent Reports (Showing 1 to 10 of 21)
Release
Date [down]		 Contributor Author Title Pages Price More Info
22-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: MEDIVATION INC5$25View Abstract
21-Nov-09Standard & Poor's Quantitative ReportN/AMedivation Inc5$25View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: MEDIVATION -- MDVN1$4View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: CADX , MNKD , MDVN , NVD -- DRUGS3$4View Abstract
17-Nov-09EconomicInvestorN/A"The Economy Matters" Report for MDVN: the economy's impact on MDVN's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
15-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for Medivation, Inc.40$65View Abstract
15-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: MEDIVATION INC5$25View Abstract
8-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: MEDIVATION INC5$25View Abstract
8-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: MEDIVATION INC5$25View Abstract
1-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: MEDIVATION INC5$25View Abstract
Next 11

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.